Avondale Wealth Management »

Biogen Idec shares owned by Avondale Wealth Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Avondale Wealth Management from 13F filings

Historical chart of Avondale Wealth Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Avondale Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Avondale Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $29k 110 258.77
2023-09-30 $28k 110 257.01
2023-06-30 $31k 110 284.85
2023-03-31 $31k 110 278.03
2022-12-31 $31k 110 276.92
2022-09-30 $29k 110 263.64
2022-06-30 $22k 110 200.00
2022-03-31 $23k 110 209.09
2021-12-31 $26k 110 236.36

More positions owned by Avondale Wealth Management

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Mid Cap Etf Etf (IJH)
Invesco Qqq Trust Series I Etf (QQQ)
Pacer Us Small Cap Cash Cows 100 Etf Etf (CALF)
Dimensional Emerging Core Equity Market Etf Etf (DFAE)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Dimensional Us High Profitability Etf Etf (DUHP)
Vanguard S&p 500 Etf Etf (VOO)
Berkshire Hathaway Inc Del Cl A Stock (BRK.A)
Energy Select Sector Spdr Etf (XLE)
Apple Stock (AAPL)
Ishares U.s. Treasury Bond Etf Etf (GOVT)
Spdr S&p Regional Banking Etf Etf (KRE)
Sentinelone Inc Cl A Stock (S)
Draftkings Inc New Com Cl A Stock (DKNG)

View all positions for Avondale Wealth Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
Wellington Management Company
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Van Eck Associates Corp.
Morgan Stanley
T. Rowe Price Associates
ClearBridge Advisors
Legal & General Group
Northern Trust
Bank of New York Mellon
Dimensional Fund Advisors

View all funds holding Biogen Idec